Sort
11,323 grants matching “glioblastoma”
Augmented homologous recombination as a mechanism of acquired temozolomide resistance in glioblastoma
$211,410Sandeep Burma · Ut Southwestern Medical Center · R21 · FY2017 · CA
Design of Therapeutic Strategies Specific for Breast Cancer Initiating Cells
$211,324Germana Rappa · Nevada Cancer Institute · R01 · FY2009 · CA
Metabolic and molecular regulation of myeloid cell functions in brain cancer
$211,285Filippo Veglia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · NS
Novel CXCR4 Therapeutics to Block Bevacizumab-Induced Glioma Dissemination.
$211,250David Zagzag · New York University School Of Medicine · R21 · FY2012 · NS
Tracing Hypoxic State and Hypoxia Memory in Glioblastoma Progression
$211,250Roland Horst Friedel · Icahn School Of Medicine At Mount Sinai · R21 · FY2023 · NS
Optimizing Measles Virotherapy in the Treatment of Gliomas
$211,214Evanthia Galanis · Mayo Clinic Rochester · P50 · FY2013 · CA
Receptor Crosstalk in HNSCC Metastatic Progression
$211,095Steven A. Rosenzweig · Medical University Of South Carolina · R01 · FY2013 · CA
Core 1: Biospecimen and Pathology Core (BiPC)
$211,032Fausto Rodriguez · University Of California Los Angeles · P50 · FY2024 · CA
Optimizing Measles Virotherapy in the Treatment of Gliomas
$210,893Evanthia Galanis · Mayo Clinic Rochester · P50 · FY2015 · CA
Administrative and Clinical Services Core
$210,859Susan M Chang · University Of California, San Francisco · P01 · FY2016 · CA
Novel oncolytic virotherapy for brain tumors
$210,845Hiroaki Wakimoto · Massachusetts General Hospital · R21 · FY2017 · NS
Administrative and Clinical Services Core
$210,843Susan M Chang · University Of California, San Francisco · P01 · FY2014 · CA
Receptor Tyrosine Kinase/PTEN Interactions in Gliomas
$210,780Roger Abounader · University Of Virginia · R01 · FY2007 · NS
Regulation of Neuroinflammation by Meningeal Lymphatics
$210,750Zsuzsanna Fabry · University Of Wisconsin-Madison · R01 · FY2024 · NS
Efficacy of Distant Healing in Glioblastoma Treatment
$210,715California Pacific Med Ctr Res Institute · R01 · FY2003 · AT
Phosphoinositide Regulation of Focal Adhesion Structure
$210,707Jeffrey A Greenwood · Oregon State University · R01 · FY2006 · GM
Extrachromosomal DNA as a Targetable Mechanism in Glioblastoma
$210,638Roel Gw Verhaak · Jackson Laboratory · R01 · FY2023 · CA
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastoma
$210,600Hugo Guerrero-Cazares · Mayo Clinic Jacksonville · K01 · FY2022 · NS
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastoma
$210,600Hugo Guerrero-Cazares · Mayo Clinic Jacksonville · K01 · FY2019 · NS
Effect on IL-2R Antibody on Regulatory T-cells in Patients with Malignant Gliomas
$210,600John H Sampson · Duke University · R21 · FY2008 · CA
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastoma
$210,600Hugo Guerrero-Cazares · Mayo Clinic Jacksonville · K01 · FY2021 · NS
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastoma
$210,600Hugo Guerrero-Cazares · Mayo Clinic Jacksonville · K01 · FY2020 · NS
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastoma
$210,600Hugo Guerrero-Cazares · Mayo Clinic Jacksonville · K01 · FY2023 · NS
Dual Targeting of Brain Tumor Initiating Cells through Inhibition of BMI1 and EZH2
$210,473Jeremy N Rich · University Of California, San Diego · R01 · FY2020 · NS
Development of single cell magnetophoresis to analyze and isolate glioma cancer stem cells
$210,426Jeffrey John Chalmers · Ohio State University · R21 · FY2021 · CA